ISLAA

🏁 #ISLAA2026 — WRAPPED. 8 sessions. 11 live cases. 3 continents. Founders' Lecture. Novel pipeline. DRT masterclass. Factor XIa debate. Edge cases that stay with you. Two days that advanced the global standard of LAOO care. See you at #ISLAA2027. 🫀 #LAOO #EP #AFib #LAAClosure

Dr. Joshua Chung at #ISLAA2026: Hybrid epicardial ablation+Lariat/Atriclip LAA exclusion-for ablation failures, complex anatomies,concomitant surgical indications.Completeness that neither catheter-only nor device-only approach achieves. #HybridAblation #Lariat #Atriclip

🔬 Dr. Himanshu Agarwal at #ISLAA2026: TAVR + LAOO—staged vs. concomitant, femoral access sharing, contrast load, dual anticoagulation obligations. An increasingly common combination in the ageing structural heart disease-AFib population. 🫀#TAVR #LAOO #StructuralHeartDisease

🔬 Dr. Saibal Kar at #ISLAA2026: speaking about Feasibility and Safety of same day MTEER And LAOO. 🫀 #MTEER #MitraClip #LAOO #StructuralHeartDisease #EP

⚠️ Dr. Lakkireddy at #ISLAA2026: Pseudo-embolization from TTE parallax error. Device was fine — image said otherwise. TEE/CT confirmation before escalation for suspected embolisation: non-negotiable. TTE alone is insufficient. Full stop. 🫀#PseudoEmbolization #ParallaxError

🔬 Rare case at #ISLAA2026: Dr. Gopinathannair—intramural atrial thrombus after LAOO. Within the atrial wall. TEE and CT may miss it entirely. Challenges our follow-up protocols and our understanding of post-LAOO thrombosis. 🫀#IntramularThrombus #LAOO #RareCases #PostLAAO #EP

📡 Session 16 at #ISLAA2026: Miscellaneous Case-Based Learning — rare, complex, humbling edge cases. Cases that don't fit guidelines teach the deepest lessons. 🫀 #CaseLearning #LAOO #EP #RareCases

💬 Session 15 Panel at #ISLAA2026 — OAC vs LAOO, Factor XIa challenge, brain imaging selection, AF-CAD complexity. LAOO is powerful. Stroke prevention in AFib is multi-modal. Both truths apply simultaneously. 🫀 #AFib #LAOO #OAC #StrokePrevention #FactorXIa #EP

🔥 Boldest question at #ISLAA2026: Will Factor XIa inhibitors make LAOO redundant? Abelacimab, asundexian, milvexian — OAC efficacy, minimal bleeding. If haemorrhage is solved, is the mechanical case over? #FactorXIa #LAOO #AFib #StrokePrevention

🔥 Boldest question at #ISLAA2026: Will Factor XIa inhibitors make LAOO redundant? Abelacimab, asundexian, milvexian — OAC efficacy, minimal bleeding. If haemorrhage is solved, is the mechanical case over? #FactorXIa #LAOO #AFib #StrokePrevention

QnA with Edip Gurol on - Role of Brain Imaging in Choosing OAC vs LAOO in AF

🧠 Dr. Edip Gurol at #ISLAA2026: Brain MRI microbleeds (SWI), white matter hyperintensities (FLAIR), cortical siderosis—neuroimaging biomarkers tipping OAC vs LAOO decision. The patient with microbleeds=your clearest LAOO indication. Practice-changing. #BrainImaging #MRI

💬 Session 15 Panel at #ISLAA2026 — OAC vs LAOO, Factor XIa challenge, brain imaging selection, AF-CAD complexity. LAOO is powerful. Stroke prevention in AFib is multi-modal. Both truths apply simultaneously. 🫀 #AFib #LAOO #OAC #StrokePrevention #FactorXIa #EP

💡 Dr. Jalag Garg at #ISLAA2026: DCCV after LAOO — imaging requirements (TEE alone? CT?), timepoint post-implant, OAC bridging, and management when DRT is found at pre-DCCV workup. Guideline gaps with real consequences. 🫀 #DCCV #LAOO #PostLAAO #OAC #TEE #EP

📡 Session 15 LIVE at #ISLAA2026: AF & Stroke — substrate, APT, OAC, and the expanding toolkit. LAOO, NOACs, Factor XIa inhibitors, ablation — how do they integrate intelligently in 2026? 🫀 #AFib #StrokePrevention #OAC #APT #LAOO #EP

💬 Session 14 Panel at #ISLAA2026 — DRT definition to aspiration: the most complete clinical DRT framework outside a formal guideline. Know it. Use it. 🫀 #DRT #LAOO #EP

🔬 Dr. Vivek Reddy at #ISLAA2026: DRT pathophysiology — Flow dynamic factors & DRT, Watchman vs Amulet, Managing DRT. 🫀 #DRT #LAOO #Endothelialization #EP

🔬 Dr. Andrea Natale at #ISLAA2026: Device design and DRT-fabric chemistry, face geometry (flat/concave/convex), strut exposure, dual-seal vs. single-plug endothelialisation differences. DRT rate variation between platforms is mechanistically explainable. Design IS the lever.

🎥 Case in the Box at #ISLAA2026: Dr. Andrea Natale - Flowrunner catheter DRT aspiration! Pharmacology failed → mechanical aspiration over the device face. Targeted, precise, thrombolytic-free. Compelling option for large/mobile DRT. #DRT #Flowrunner #DRTAspiration #LAOO #EP

💊 Dr. Amin Al-Ahmad at #ISLAA2026: Discussing Pharmacological Interventions For Treatment of DRT & Post-Implant Regimens to Prevent DRT🫀 #DRT #LAOO #NOAC #OAC #Anticoagulation #CHAMPION